Uihlein Richard E bought GALT
January 16, 2026 · Form 4 insider transaction
Uihlein Richard E bought 13,158 shares of Galectin Therapeutics Inc. at $3.04 per share, a transaction worth $40.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,158
Price
$3.04
Total value
$40.0K
InsiderUihlein Richard E
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after10,332,676
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted shares were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan in lieu of a cash retainer and meeting fees of $40,000 for 2026. Restrictions on the shares lapse at a rate of 25% at the end of each calendar quarter in 2026.